Lembos Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in New Delhi, Delhi, India, established in 2015.
2015 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Lembos Pharmaceuticals Llp

Lembos Pharmaceuticals Llp, a active limited liability partnership, was established on 28 November 2015 in New Delhi, Delhi, India. Engaging in pharmaceutical products within the pharma sector, it holds LLPIN: AAF-2347. Registered under ROC Roc Delhi Ii. It has total obligation of contribution of ₹0.15 M.

Its leadership includes Ajay Prem Juneja (Designated Partner), Dewashish Pathak (Designated Partner), Dilip Kumar (Designated Partner). Its latest date of accounts and solvency statement 31 March 2023. It is based at H. No.-508/6, Kh No-1529, Gf, Blk-Z, Basai Darapur Near Ramesh Nagar Metro Station, New Delhi, Delhi, 110027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAF-2347

  • Incorporation Date

    28 November 2015

  • Total Obligation of Contribution

    ₹0.15 M

  • ROC Code

    Roc Delhi Ii

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.15 M
  • Company Age 10 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Lembos Pharmaceuticals Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Lembos Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lembos Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Ajay Prem Juneja Designated Partner 28 Nov 2015 Current
Dewashish Pathak Designated Partner 28 Nov 2015 Current
Dilip Kumar Designated Partner 28 Nov 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lembos Pharmaceuticals Llp.

Enhance accessibility to Lembos Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Lembos Pharmaceuticals Llp revenue growth over time
Lembos Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lembos Pharmaceuticals Llp?

Unlock access to Lembos Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lembos Pharmaceuticals Llp?

Unlock and access historical data on people associated with Lembos Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lembos Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lembos Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lembos Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Lembos Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Lembos Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi Ii. was documented.

  • Director Appointment

    The activity Ajay Prem Juneja was appointed as a Designated Partner was appointed as a Designated Partner on 28 Nov 2015 & has been associated with this company since 10 years 7 months . was completed.

  • Director Appointment

    Progress on Dewashish Pathak was appointed as a Designated Partner was appointed as a Designated Partner on 28 Nov 2015 & has been associated with this company since 10 years 7 months . was documented.

  • Director Appointment

    Progress on Dilip Kumar was appointed as a Designated Partner was appointed as a Designated Partner on 28 Nov 2015 & has been associated with this company since 10 years 7 months . was documented.

  • LLP Incorporation

    Lembos Pharmaceuticals Llp was registered on 28 Nov 2015 with Roc Delhi Ii & aged 10 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Lembos Pharmaceuticals Llp?

The LLPIN of Lembos Pharmaceuticals Llp is AAF-2347.

Where is Lembos Pharmaceuticals Llp headquartered?

Lembos Pharmaceuticals Llp is headquartered at H. No.-508/6, Kh No-1529, Gf, Blk-Z, Basai Darapur Near Ramesh Nagar Metro Station, New Delhi, Delhi, 110027.

When was Lembos Pharmaceuticals Llp incorporated?

Lembos Pharmaceuticals Llp was incorporated on 28 November 2015.

Who are the current directors of Lembos Pharmaceuticals Llp?

The current directors of Lembos Pharmaceuticals Llp are

What is the primary industry of Lembos Pharmaceuticals Llp?

The primary industry of Lembos Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available